ArticleBlood transfusion = Trasfusione del sangue2013

Early measurement of CD34+ cells in peripheral blood after cyclophosphamide and granulocyte colony-stimulating factor treatment predicts later CD34+ mobilisation failure and is a possible criterion for guiding "on demand" use of plerixafor.

Giuseppe Milone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.